Navigation Links
Forgotten, but not gone: Leprosy still present in the US
Date:11/7/2008

Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States. "Approximately 150 cases are diagnosed each year with 3,000 people in the U.S. currently being treated for leprosy, says James Krahenbuhl, Ph.D., director of the Health Resources Service Administration's National Hansen's Disease Program (NHDP) in Baton Rouge, LA. "We believe there are more cases of leprosy not identified due to the lack of awareness about the disease among physicians in the U.S., which is leading to misdiagnosis and wrong treatments for patients who are left to suffer with the debilitating damage caused by this disease."

Although researchers do not clearly understand how leprosy is transmitted, they do know that it is a slow, chronic disease that attacks the peripheral nervous system and motor skills often leading to disability and disfigurement. According to the NHDP, the onset of infection and symptoms can take three to 10 years, making it difficult for researchers to find the origin of where or how people acquire the disease. As the disease progresses, patients lose their sense of touch in their fingers and toes leaving them open to repeated burns and cuts which then get infected. The effects of repeated damage will initiate bone absorption and motor nerve deterioration causing fingers to shorten and curve, resulting in a claw-like appearance. Although leprosy can be fully treated with medicine when diagnosed in early stages, once the disease has advanced nerve damage cannot be reversed.

Because many of the population in the U.S. affected by leprosy are immigrants in poor communities who primarily seek treatment in free clinics or emergency rooms, the NHDP says that many of those physicians are not familiar with the disease to make an accurate diagnosis. Therefore, many physicians mistake the skin lesions of leprosy for a fungus or ringworm and treat it with a topical cream. And, because leprosy is a slow-progressing disease, it can take months, if not longer, before the doctor or the patient realizes that the treatment isn't working giving the disease enough time to start destroying the nervous system.

Leprosy is most prevalent in the tropics and third world countries where there are poor living conditions and limited access to medical care. Due to changes in immigrant relocation, leprosy is now being diagnosed throughout the U.S. The NHDP sees approximately 30 cases each year among residents in southern Louisiana and the Gulf Coast of Texas who were born in the U.S. and who have never visited an endemic country. "As we see leprosy move toward internal regions of the States, it becomes more urgent to reach those physicians to let them know about the symptoms of this disease," explains Dr. Krahenbuhl. Dr. James Krahenbuhl will lead a symposium at the American Society of Tropical Medicine and Hygiene meeting to raise awareness among physicians that leprosy is in the U.S. and assistance and treatments are available.


'/>"/>

Contact: Rosalind D'Eugenio
rdeugenio@environics-usa.com
203-325-8772
American Society of Tropical Medicine and Hygiene
Source:Eurekalert

Related medicine news :

1. New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
2. There's Still Time to Ensure Your Turkey Neck Doesn't Make an Appearance at Thanksgiving Dinner Thanks to Innovative Tuliplift
3. U.S. Experts Still Unsure of Allergy Relief by Mouth
4. Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
5. Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup
6. Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage
7. Role of Circumcision in Reducing HIV Risk Still Unclear
8. Patients in Minimally Conscious State May Still Feel Pain
9. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
10. Kabul Under Virtual Lockdown for International Travelers, Progress Still Evident for Women's Programs
11. Big Tobaccos Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the ... in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on ... health management. , ODH will also have an exhibit booth where attendees may speak ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to sharpen ... With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal ... color spectrum tools users can visually see the color range effected with ease all ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of ... critically important that we all are aware of our options and are empowered ... to announce the launch of its newest edition of "Vision and Hearing" in ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: